Mindfulness-Based Relapse Prevention for Substance Use Disorders
RAND researchers conducted a systematic review that synthesized evidence from randomized controlled trials of Mindfulness-Based Relapse Prevention (MBRP)—used as an adjunctive therapy or monotherapy—to provide estimates of its efficacy and safety for treating adults diagnosed with alcohol, opioid, s...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Online |
| اللغة: | الإنجليزية |
| منشور في: |
RAND Corporation
2023
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | ONIX_20231005_9780833093424_1332 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| الملخص: | RAND researchers conducted a systematic review that synthesized evidence from randomized controlled trials of Mindfulness-Based Relapse Prevention (MBRP)—used as an adjunctive therapy or monotherapy—to provide estimates of its efficacy and safety for treating adults diagnosed with alcohol, opioid, stimulant, or cannabis use disorder. |
|---|